Go offline with the Player FM app!
BioPharma EHS Podcast Episode No. 18
Manage episode 156330780 series 1185076
Nanotechnology and the Pharmaceutical Industry - an interview with Don Ewert of OSO Biopharmaceuticals.
Hello everybody and welcome back to another episode of the BioPharma EH&S Podcast, my name is Dean Calhoun of Affygility Solutions and this is the podcast dedicated to discussing critical environmental, health and safety issues facing the biopharma industry, helping you take your environmental, health and safety programs to the next level.
Overview
I’ll briefly cover what we talked about last time in episode number 17
Then I will cover our main topic for today, which is an interview with Don Ewert, Environmental, Health and Safety Manager for OSO Biopharmaceuticals. In this interview Don and I will discuss nanotechnology and some of the key environmental, health and safety issues surrounding this emerging technology
And finally, we’ll discuss upcoming events and happenings of importance to environmental, health and safety professionals in the BioPharma Industry.
So, without further delay, let’s go ahead get started. Last time in Episode number 17 we discussed the topic of “Containment Validation and Surrogate Monitoring.” In that Podcast, Matt Meiners, Laboratory Services Manager for Bureau Veritas and I discussed what is surrogate monitoring, some of the key factors to consider when selecting a surrogate compound, and finally, what are some of the common mistakes that occur when performing containment validation and surrogate monitoring. It was a great interview, and I appreciate Matt taking the time out of his busy schedule to participate. If that’s something that may interest you, I would suggest that you go back and listen to Episode 17.
Alright, let’s now move on to our main topic for today which is an interview with Don Ewert, Environmental, Health and Safety Manager on nanotechnology. I should mention ahead of time, that this section of the podcast was recorded on January 19th, 2012 via Skype. There is a few instances where we have a Skype garble moment, so I do apologize in advance for that. So without further delay, here we go.
[audio portion]
O.k., that does it for our main topic, let’s now talk about some upcoming events.
The first set of events that I would like to mention is in early February. In February, Affygility Solutions has several webinars starting and I would suggest that look at our schedule at Affygility.com. These webinars have been extremely popular and we have received a lot of positive feedback on them. In February, we have a new webinar on Manufacturing Highly Potent Compounds – Understanding and Controlling the Risks. This is a brand new webinar and we are very excited to be premiering it. It you are an certified industrial hygienist and involved in potent compound safety, certification points are available. Additional webinars for the month of February include our every popular isoflurane safety webinar. Again, if any of that interests you, I would suggest that you go to Affygility.com and look at our full schedule.
The next event that I would like to mention is the annual Society of Toxicology conference to be held on March 11th through 15th in San Francisco. Affygility Solutions won’t be exhibiting at this conference, but our Senior Toxicologist, Joe Nieusma, may be attending. If you would like more information on this conference go to the Society of Toxicology’s website at sot.org
Then at the end of March, the Society of Chemical Hazard Communication will be having it’s Spring Meeting in Nashville, TN. We haven’t decided if we will attend this meeting or not, but in any case, these are usually very informative event and with GHS due to be finalize in early 2012 I’m sure there will be great sessions. You should go to their website for more information. The URL for their website will be in the show notes.
O.k. That does it for this week’s show. Remember to submit your questions to our podcast email at podcast at Affygility.com. You can also follow us on twitter at twitter.com/Affygility, on Facebook at facebook.com/affygilitysolutions and giving us a “Like”, and finally on LinkedIn by searching for Affygility Solutions.
That does it for this week’s show. We look forward to having you listen in next time.
About Affygility Solutions. Affygility Solutions provides environmental, health and safety software and services to the pharmaceutical, biotechnology, and medical device industry.
Have a great rest of the day.
28 episodes
Manage episode 156330780 series 1185076
Nanotechnology and the Pharmaceutical Industry - an interview with Don Ewert of OSO Biopharmaceuticals.
Hello everybody and welcome back to another episode of the BioPharma EH&S Podcast, my name is Dean Calhoun of Affygility Solutions and this is the podcast dedicated to discussing critical environmental, health and safety issues facing the biopharma industry, helping you take your environmental, health and safety programs to the next level.
Overview
I’ll briefly cover what we talked about last time in episode number 17
Then I will cover our main topic for today, which is an interview with Don Ewert, Environmental, Health and Safety Manager for OSO Biopharmaceuticals. In this interview Don and I will discuss nanotechnology and some of the key environmental, health and safety issues surrounding this emerging technology
And finally, we’ll discuss upcoming events and happenings of importance to environmental, health and safety professionals in the BioPharma Industry.
So, without further delay, let’s go ahead get started. Last time in Episode number 17 we discussed the topic of “Containment Validation and Surrogate Monitoring.” In that Podcast, Matt Meiners, Laboratory Services Manager for Bureau Veritas and I discussed what is surrogate monitoring, some of the key factors to consider when selecting a surrogate compound, and finally, what are some of the common mistakes that occur when performing containment validation and surrogate monitoring. It was a great interview, and I appreciate Matt taking the time out of his busy schedule to participate. If that’s something that may interest you, I would suggest that you go back and listen to Episode 17.
Alright, let’s now move on to our main topic for today which is an interview with Don Ewert, Environmental, Health and Safety Manager on nanotechnology. I should mention ahead of time, that this section of the podcast was recorded on January 19th, 2012 via Skype. There is a few instances where we have a Skype garble moment, so I do apologize in advance for that. So without further delay, here we go.
[audio portion]
O.k., that does it for our main topic, let’s now talk about some upcoming events.
The first set of events that I would like to mention is in early February. In February, Affygility Solutions has several webinars starting and I would suggest that look at our schedule at Affygility.com. These webinars have been extremely popular and we have received a lot of positive feedback on them. In February, we have a new webinar on Manufacturing Highly Potent Compounds – Understanding and Controlling the Risks. This is a brand new webinar and we are very excited to be premiering it. It you are an certified industrial hygienist and involved in potent compound safety, certification points are available. Additional webinars for the month of February include our every popular isoflurane safety webinar. Again, if any of that interests you, I would suggest that you go to Affygility.com and look at our full schedule.
The next event that I would like to mention is the annual Society of Toxicology conference to be held on March 11th through 15th in San Francisco. Affygility Solutions won’t be exhibiting at this conference, but our Senior Toxicologist, Joe Nieusma, may be attending. If you would like more information on this conference go to the Society of Toxicology’s website at sot.org
Then at the end of March, the Society of Chemical Hazard Communication will be having it’s Spring Meeting in Nashville, TN. We haven’t decided if we will attend this meeting or not, but in any case, these are usually very informative event and with GHS due to be finalize in early 2012 I’m sure there will be great sessions. You should go to their website for more information. The URL for their website will be in the show notes.
O.k. That does it for this week’s show. Remember to submit your questions to our podcast email at podcast at Affygility.com. You can also follow us on twitter at twitter.com/Affygility, on Facebook at facebook.com/affygilitysolutions and giving us a “Like”, and finally on LinkedIn by searching for Affygility Solutions.
That does it for this week’s show. We look forward to having you listen in next time.
About Affygility Solutions. Affygility Solutions provides environmental, health and safety software and services to the pharmaceutical, biotechnology, and medical device industry.
Have a great rest of the day.
28 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.